Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001493152-26-004760·ABG Management Ltd.
Schedule 13D ownership disclosure
PROMIS NEUROSCIENCES INC
Common Shares, no par value per share · CUSIP: 74346M406
Event date: 2026-01-29
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ABG Management Ltd.Reported CIK 0001832106
Shares: 6,070,405.00 · Class: 11.3%
- Ally Bridge Group (NY) LLCReported CIK 0001822947
Shares: 6,070,405.00 · Class: 11.3%
- Ally Bridge MedAlpha Master Fund L.P.Reported CIK 0001831963
Shares: 6,070,405.00 · Class: 11.3%
- Fan YuReported CIK 0001668029
Shares: 6,070,405.00 · Class: 11.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-26-004760
- Form type
- SCHEDULE 13D/A
- Filer
- ABG Management Ltd.
- CIK
- CIK 1832106
- Filed
- Feb 02, 2026
- Reporting period
- Jan 29, 2026
- Description
- Schedule 13D beneficial ownership